Michael Jackson was not abusing pain medication in the years leading up to his comeback tour deal with concert promoter AEG Live, a doctor testified on Wednesday.
Dr. Sidney Schnoll, who based his opinion on medical records, stated that the late singer required only 100 milligrams of the narcotic pain medication Demerol to knock him out for a dermatology procedure in late 2008, the New York Daily News reported.
Schnoll, who was acting as a paid expert witness for Jackson's mother, Katherine, told jurors that the King of Pops would have built up too much tolerance for that dose to work if he frequently abused opioids during the era of his 2005 molestation trial and subsequent travels abroad.
Katherine is suing AEG Live for wrongful death of the late singer, while claiming that the concert promoter negligently hired Dr. Conrad Murray as tour physician and set the stage for her son's fatal 2009 overdose.
During his testimony, Schnoll said that he didn't believe Michael was an addict who craved and used drugs recreationally; instead he was a patient who developed an opioid dependence because of legitimate pain related to his burned scalp.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
